Azedra should be used by or under the control of physicians who are qualified by specific training and experience in the safe use and handling of radiopharmaceuticals.
A 33-year-old previously healthy woman, gravida 1, para 0, presented during her first trimester with palpitations and an increase in sweating.
New recommendations include biochemical tests for diagnosis, genetic testing and personalized management for pheochromocytomas and paragangliomas.
Many patients with adrenal incidentaloma may not receive the necessary care for their condition.
Endocrinology Advisor Articles
- Heritability of BMI Stronger in Obesogenic Environments
- Adverse Events Associated With Diazoxide Treatment for Congenital Hyperinsulinism
- Maternal Gluten Intake Associated With Risk for Type 1 Diabetes in Offspring
- Patterns of Evidence-Based Diabetes Interventions at Local Health Departments
- Bone-Derived Factors in the Treatment of Diabetes
- Vitamin D Supplementation Has No Effect on Musculoskeletal Health
- Deep Learning Algorithm Efficiently Detects Vision-Threatening Diabetic Retinopathy
- Industry-Funded Trials Often Involve Employees in Studies
- Nutrition Tips for Physicians: Staying Healthy During Busy Days
- Early-Onset Asthma/Wheezing Associated With Later Childhood Obesity